MedTrace Logo

Immune Response to Influenza Vaccination

NCT00551837 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 82

Last updated 2017-10-24

No results posted yet for this study

Summary

The purpose of this study is to evaluate the immune response to a routine influenza vaccination. Influenza vaccination is given as part of routine standard of care in these individuals and is not part of the study protocol. The study will evaluate for a change in response to common antigens over time after influenza vaccination to determine if changes are related to the development of chronic rejection after solid-organ transplantation. We hypothesize that the influenza vaccine contributes to the alloreactivity of T cells verses common HLA types in the donor pool.

Conditions

Sponsors & Collaborators

  • University Hospitals Cleveland Medical Center

    collaborator OTHER

  • The Cleveland Clinic

    lead OTHER

Principal Investigators

  • Emilio Poggio, MD · The Cleveland Clinic

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-11-30
Primary Completion
2008-04-30
Completion
2008-05-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00551837 on ClinicalTrials.gov